Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Atiprimod

Generic Name: Atiprimod

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₄₄N_₂

CAS Number: 123018-47-3

Unique Ingredient Identifier: MG7D3QD743

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in cancer/tumors (unspecified), multiple myeloma, and rheumatoid arthritis.

Associated Conditions

No associated conditions information available.

Clinical Trials

Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma

Phase 2

Completed

Posted: 2008/04/22

Sponsor:Callisto Pharmaceuti...

ID:NCT00663429

Study of Atiprimod Treatment for Patients With Advanced Cancer

Phase 1

Terminated

Posted: 2007/02/01

Sponsor:M.D. Anderson Cancer...

ID:NCT00430014

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Phase 2

Completed

Posted: 2006/10/13

Sponsor:Callisto Pharmaceuti...

ID:NCT00388063

An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer

Phase 1

Posted: 2005/09/22

Sponsor:Callisto Pharmaceuti...

ID:NCT00214838

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

Phase 1

Completed

Posted: 2004/06/30

Sponsor:Callisto Pharmaceuti...

ID:NCT00086216

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy